Eligard
1 known investors
ELIGARD is a GnRH agonist medication in injectable form used to treat prostate cancer by reducing testosterone production. The product offers multiple dosing schedules for patients with metastatic castration-sensitive prostate cancer.
Investors · 1
Frequently asked questions
- What does Eligard do?
- ELIGARD is a GnRH agonist medication in injectable form used to treat prostate cancer by reducing testosterone production. The product offers multiple dosing schedules for patients with metastatic castration-sensitive prostate cancer.
- Who are Eligard's investors?
- Eligard's investors include HEALTHCARE ROYALTY PARTNERS.